HAND2 and endometrial cancer: We found that HAND2 methylation is able to predict response to progesterone and provides a sensitive test to correctly identify endometrial cancer patients amongst those women who present with postmenopausal bleeding through the DNAme analysis of endometrial secretions on high vaginal swabs.